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The Ion Channel-Kinase, TRPM7, is Required for Cardiac Automaticity
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Sick sinus syndrome and atrioventricular block are common clinical problems,
often necessitating permanent pacemaker placement, yet the pathophysiology
of these conditions remains poorly understood. Here we show that Transient
Receptor Potential Melastatin 7 (TRPM7), a calcium-permeant channel-kinase
highly expressed in heart, is required for cardiac automaticity, sinoatrial node
(SAN) and atrioventricular node (AVN) function. We find larger TRPM7 cur-
rents in myocardial cells exhibiting automaticity such as embryonic ventricular
myocytes (EVM) and SAN cells, as compared to quiescent adult ventricular
myocytes. TRPM7 disruption in cultured EVM reduces spontaneous Ca2þ
transient firing rates, impairing automaticity in vitro. Likewise, morpholino
mediated TRPM7 knock-down in zebrafish embryo slows heart rate in vivo.
Cardiac-targeted TRPM7 deletion in mouse (KO) eliminates TRPM7 current
in SAN, inducing episodes of sinus pauses, AVN block and cardiomyopathy.
Freshly isolated SAN from KO mice exhibit diminished Ca2þ transient firing
rates and a blunted diastolic Ca2þ rise. Moreover, action potential firing rates
are diminished in KO SAN due to slower diastolic depolarization. Accordingly,
Hcn4 mRNA and the pacemaker current, If, are diminished in both SAN and
AVN fromKOmice. We conclude that TRPM7 both regulates Hcn4 expression
and provides a novel, previously unrecognized diastolic Ca2þ current at
hyperpolarized membrane potentials, each contributing to diastolic membrane
depolarization and myocardial automaticity in SAN and AVN.
Platform: Protein-Ligand Interactions
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Intrinsically disordered proteins (IDPs) are involved in a wide variety of human
diseases (1). Hence, interfering with the function of IDP-disease-associated
proteins offers a highly attractive objective for drug development (2). Unfortu-
nately, rational approaches have been hampered so far because of variety of
problems absent in traditional drug design protocols. These issues include
the highly dynamic nature of IDPs (3), the presence of local and long-range
conformational rearrangements (4), transient secondary structure, transient
long-range tertiary structure (5, 6).
Here we present a combined NMR/molecular dynamics protocol that provides
quantitative information on ligand poses to IDPs. The approach is based on
a geometrical-based analysis of MD trajectory with a flexibility index able to
detect conformational transition of residues’ backbone (Caliandro, C, Rossetti,
G, Carloni, P, 2012 JCTC in press). The protocol is applied on dopamine in
complex with the naturally unfolded protein human a-synuclein. The proposed
protocol is very general and it could be used to investigate the pose of novel
molecules binding to any IDP.
1. Babu MM, et al. (2011). Current Opinion in Structural Biology 21(3):
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Islet amyloid polypeptide (IAPP) is a 37-residue peptide hormone, which is
co-secreted with insulin by the b-cells of the endocrine pancreas. IAPP belongs
to a class of aggregation prone proteins, which includes Ab from Alzheimer’s,in which a wild-type protein precursor irreversibly forms/folds into b-sheet rich
fibrillar amyloid plaques. The aggregation of IAPP results in b-cell dysfunction
that leads to type 2 diabetes. Even though the mechanism behind the cell
toxicity is poorly understood, recent reports suggest that the membrane bound
intermediate oligomeric helical states mediate the cell toxicity and not the
aggregated state.
The overall hypothesis pursued in this study is that small-molecule, structure
based targeting of pre-amyloidogenic states will enable elucidation of the
mechanism of IAPP induced cytotoxicity. These efforts provide novel descrip-
tions of IAPP oligomerization at a molecular level, and provide a rational de-
sign path for the creation of lead compounds that ameliorate b-cell death.
Importantly, we are targetting the a-helical intermediates of IAPP by synthesiz-
ing small molecules designed to mimic the surface presentation of one edge of
an a-helix. Interaction studies between helical mimetic compounds and IAPP
will be presented.
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A crystallographically-defined bile acid binding site has been identified in the
membrane domain of mammalian and Rhodobacter sphaeroides cytochrome
c oxidase (RsCcO). Previous studies indicate that several amphipathic mole-
cules including detergents, fatty acids, and porphyrins also bind to this site
and alter K-pathway dependent electron transfer between heme cofactors.
Current studies are aimed at identifying physiological ligands specific for
this site using several computational approaches, including: ROCS comparison
of ligand shape and electrostatics, SimSite3D analysis of similarity to ligand
binding sites in the Protein Data Bank, and SLIDE screening of small molecules
by docking. Together, the results suggest several steroids, adenine and guanine
deoxyribonucleotides, NADþ, FAD, and phosphorylated isoprenes as top can-
didates for interacting at this site, along with bile acids and porphyrins.
Deoxyriboside-containing ligands are all predicted to bind to this site by mak-
ing key protein contacts with Pro315, His96, Ser98, Glu101, and Thr105, as
seen in bile acid binding. Invitro oxygen consumption assays support some
of these predicted interactions. In the wildtype RsCcO, the steroidal antibiotic
fusidic acid and T3 thyroid hormone inhibit the enzyme, while in the RsCcO
E101A mutant, fusidic acid has a stimulatory effect and an ATP analog and
T3 thyroid hormone inhibit activity. Cytochrome c titration assays indicate
that nucleotides also inhibit the E101A mutant enzyme at lower cytochrome
c concentrations. The confirmed prediction of new ligands suggests that this
three-pronged computational approach may be applied to identify native
ligands in sites occupied by detergents or crystallographic additives. (supported
by NIH GM26916 to SF-M)
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Cyanovirin-N (CV-N) is a cyanobacterial lectin with potent anti-HIV activity,
mediated by binding to Man(1,2)Man with high affinity and specificity. These
sugar-binding sites are located in two quasi-symmetric domains (A and B) of
the CV-N protein. We explore the sequence space of CV-N and reengineered
CV-Nmutants with different binding affinity for the oligo-mannosides, through
integrated computational and experimental strategies. using the sequences of
two engineered CV-N,1,2 we model various CV-N mutants, and obtain these
variants in complex with di-mannose sugar with a fast and flexible docking
method called BP-Dock. BP-Dock can integrate both backbone and side chain
conformational changes in a protein through a multi-scale approach. It mimics
the nature of binding induced events by perturbation of the binding site residues
through small Brownian kicks as a first order approximation of an approaching
ligand. Then it computes the response fluctuation profile of the chains using the
perturbation response scanning method. The response fluctuation profiles are
then used to generate binding induced multiple receptor conformations of
CV-N mutants for ensemble docking. The results from docking simulation
are then validated with NMR experiments. Overall, this study helps us to
explore the sugar binding properties of CV-N mutants and provides a better
insight about the binding site of CV-N.
References:
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